Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Wins NI Hospital Trusts Business

Published: Monday, December 09, 2013
Last Updated: Monday, December 09, 2013
Bookmark and Share
Randox fought off global competition to win a five year contract to supply quality control products to the Northern Ireland Health & Social Care Trusts.

The contract will see the County Antrim firm supply quality control products to all ten hospitals within the NI Trusts. The new business is worth potentially £1.2m over the life of the contract. 

The deal means that routine patient blood tests carried out in any NHS hospital or clinic in Northern Ireland will be quality assured by Randox products developed and manufactured in Crumlin.

A high percentage of medical appointments in Northern Ireland result in patient blood samples being taken before being tested in laboratories. Diagnosis of an illness or medical condition, and the subsequent treatment prescribed, will be given by a doctor based on the results of these blood tests.

Robust Quality Control is the bedrock of patient blood testing as it helps laboratories ensure accuracy in their testing procedures. If errors occur during testing this can result in misdiagnosis and delayed treatment, which can ultimately be life threatening for the patient. 

Randox is one of the largest manufacturers of laboratory quality control products in the world. The products, all manufactured in Country Antrim, are widely considered to be the most accurate quality controls available globally. As part of the deal Randox has developed a range of customised quality controls specifically to match the clinical requirements of the NI Hospital Trusts.

Health Minister Edwin Poots, who visited Randox today as part of the announcement, said, 

“Northern Ireland’s biotechnology sector is world-class and a growing contributor to the local economy.  I am delighted that patients in Northern Ireland will now benefit from quality assured diagnostic products developed and manufactured in Crumlin.  

“Today's announcement is a further example of the positive mutual benefits to health and the economy that can result from partnership working between Government and the Pharmaceutical and Biotechnology Industry. I am keen to continue this work to ensure that we can continue to grow our pharmaceutical and biotechnology capacity in Northern Ireland.”

Steven Jordan Global Manager, Randox Quality Control lauded the positive contribution the company is making in improving the health of Northern Ireland’s population and, ultimately, saving lives.

“Randox’s reputation as a leader in diagnostics is recognised across the world. We are a ground-breaking biotechnology company, committed to revolutionising healthcare and diagnostics at a global level. We are delighted that the people of Northern Ireland will now be able to benefit from this level of global expertise, ensuring more accurate and reliable diagnosis, and improving the health outlook for all.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UK Trade and Investment Joins Hands with Randox
UK Trade and Investment organize healthcare seminars in Pakistan on “Improving Healthcare and Laboratory performance in Pakistan.”
Thursday, May 30, 2013
Newly Launched RIQAS Website Makes EQA Even Simpler for Laboratories Worldwide
www.riqas.com allows users to easily discover the many benefits offered by the world’s largest External Quality Assessment (EQA) scheme, Randox International Quality Assessment Scheme (RIQAS) and the advantages of implementing EQA in their laboratory.
Monday, March 04, 2013
You Don’t have to be a Scientist to Work in Healthcare
Randox is expanding its workforce with the recent recruitment of 42 individuals throughout October and November.
Thursday, November 15, 2012
Randox Opens New Manufacturing Facility in Bangalore, India
New Bangalore manufacturing facility to enhance product quality, ensure on time delivery and generate excellent customer satisfaction.
Friday, April 27, 2012
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!